Socioeconomic characteristics of those with peripheral artery disease in the chronic renal insufficiency cohort.
Peripheral artery disease
epidemiology
prevalence
socioeconomic status
Journal
Vascular
ISSN: 1708-539X
Titre abrégé: Vascular
Pays: England
ID NLM: 101196722
Informations de publication
Date de publication:
Feb 2023
Feb 2023
Historique:
pubmed:
29
3
2022
medline:
18
2
2023
entrez:
28
3
2022
Statut:
ppublish
Résumé
The association between socioeconomic factors and peripheral arterial disease (PAD) has not been as well characterized as other cardiovascular conditions. We sought to define how annual income and education level are associated with PAD in a well-characterized diverse set of adults with chronic kidney disease (CKD). The Chronic Renal Insufficiency Cohort Study (CRIC) is a multi-center, prospective cohort study designed to examine risk factors for progression of CKD and cardiovascular disease. Demographic, income, and education-level data, as well as clinical data including ankle-brachial index (ABI) were collected at baseline. Annual income was categorized as < $25,000, $25,000-50,000, $50,000-100,000, or above $100,000; educational level was categorized as some high school, high school graduate, some college, or college graduate. Participants with missing income data or incompressible ABI (>1.4) were excluded from initial analysis. Logistic regression was used to estimate the association of income and/or education level with PAD, defined as an enrollment ABI of <0.90, history of PAD, or history of PAD intervention. A total of 4122 were included, mean age of participants was 59.5 years, 56% were male, and 44% were Black. There were 763 CRIC participants with PAD at study enrollment (18.5%). In the final multivariable logistic regression model, Black race (OR = 1.3, 95% CI 1.1-1.6, In this prospectively followed CKD cohort, lower annual household income and Black race were significantly associated with increased PAD at study enrollment. In contrast, educational level was not associated with PAD when adjusted for patient income data. Black race, female gender, and low income were independently associated with decreased statin use, populations which could be targets of future public health programs.
Sections du résumé
BACKGROUND
BACKGROUND
The association between socioeconomic factors and peripheral arterial disease (PAD) has not been as well characterized as other cardiovascular conditions. We sought to define how annual income and education level are associated with PAD in a well-characterized diverse set of adults with chronic kidney disease (CKD).
METHODS
METHODS
The Chronic Renal Insufficiency Cohort Study (CRIC) is a multi-center, prospective cohort study designed to examine risk factors for progression of CKD and cardiovascular disease. Demographic, income, and education-level data, as well as clinical data including ankle-brachial index (ABI) were collected at baseline. Annual income was categorized as < $25,000, $25,000-50,000, $50,000-100,000, or above $100,000; educational level was categorized as some high school, high school graduate, some college, or college graduate. Participants with missing income data or incompressible ABI (>1.4) were excluded from initial analysis. Logistic regression was used to estimate the association of income and/or education level with PAD, defined as an enrollment ABI of <0.90, history of PAD, or history of PAD intervention.
RESULTS
RESULTS
A total of 4122 were included, mean age of participants was 59.5 years, 56% were male, and 44% were Black. There were 763 CRIC participants with PAD at study enrollment (18.5%). In the final multivariable logistic regression model, Black race (OR = 1.3, 95% CI 1.1-1.6,
CONCLUSIONS
CONCLUSIONS
In this prospectively followed CKD cohort, lower annual household income and Black race were significantly associated with increased PAD at study enrollment. In contrast, educational level was not associated with PAD when adjusted for patient income data. Black race, female gender, and low income were independently associated with decreased statin use, populations which could be targets of future public health programs.
Identifiants
pubmed: 35343329
doi: 10.1177/17085381211053492
pmc: PMC9515235
mid: NIHMS1810112
doi:
Substances chimiques
Hydroxymethylglutaryl-CoA Reductase Inhibitors
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
39-46Subventions
Organisme : NCATS NIH HHS
ID : UL1 TR002548
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK060963
Pays : United States
Organisme : NCRR NIH HHS
ID : UL1 RR024131
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK061022
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK119199
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR000003
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR000439
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK060990
Pays : United States
Organisme : NCRR NIH HHS
ID : UL1 RR029879
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR003098
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK061028
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR000433
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK060984
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK061021
Pays : United States
Organisme : NIDDK NIH HHS
ID : U24 DK060990
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK060980
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR000424
Pays : United States
Organisme : NCRR NIH HHS
ID : M01 RR016500
Pays : United States
Organisme : NIGMS NIH HHS
ID : P20 GM109036
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK060902
Pays : United States
Références
Circulation. 2005 Mar 15;111(10):1233-41
pubmed: 15769763
Clin J Am Soc Nephrol. 2009 Aug;4(8):1302-11
pubmed: 19541818
Am Heart J. 2008 Apr;155(4):699-705
pubmed: 18371479
Circulation. 1993 Oct;88(4 Pt 1):1973-98
pubmed: 8403348
J Am Soc Nephrol. 2003 Jul;14(7 Suppl 2):S148-53
pubmed: 12819321
J Vasc Surg. 2007 Jun;45(6):1185-91
pubmed: 17543683
PLoS One. 2013 Jun 03;8(6):e65130
pubmed: 23755180
Circ Cardiovasc Qual Outcomes. 2014 Jul;7(4):532-9
pubmed: 24987053
J Vasc Surg. 2011 Aug;54(2):420-6, 426.e1
pubmed: 21571495
Arch Surg. 1997 Aug;132(8):836-40; discussion 840-1
pubmed: 9267266
Vasc Med. 2010 Dec;15(6):443-50
pubmed: 21183651
J Gerontol B Psychol Sci Soc Sci. 2002 Jul;57(4):S247-56
pubmed: 12084794
Eur J Vasc Endovasc Surg. 2010 Jul;40(1):76-80
pubmed: 20362475
Ann Vasc Med Res. 2020;7(4):
pubmed: 33585679
JAMA. 2001 Sep 19;286(11):1317-24
pubmed: 11560536
Atherosclerosis. 2004 Jan;172(1):95-105
pubmed: 14709362
J Vasc Surg. 2006 Sep;44(3):531-6
pubmed: 16950430
Circulation. 2004 Jan 27;109(3):320-3
pubmed: 14732743
Curr Cardiol Rev. 2008 May;4(2):101-6
pubmed: 19936284
Curr Atheroscler Rep. 2018 Jun 2;20(8):40
pubmed: 29858704
Vasc Med. 2009 Nov;14(4):289-96
pubmed: 19808713
Am J Cardiol. 2008 Feb 15;101(4):462-6
pubmed: 18312758
Prev Sci. 2007 Sep;8(3):206-13
pubmed: 17549635
Am Heart J. 2005 Jun;149(6):1066-73
pubmed: 15976790
Ann N Y Acad Sci. 1999;896:191-209
pubmed: 10681898
Ann Epidemiol. 2010 Aug;20(8):617-28
pubmed: 20609342